AR expression was positively correlated with tumor-originated vasculogenesis in ccRCC patients [116], suggesting a tumor-promoting role, which was validated in in vitro experiments, possibly through modulating the lncRNA-TANAR/TWIST1 signaling pathway [116]. This evidence concerns the gene AR and neoplasm.